Avonex
NDC Package 59627-001-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Avonex is a medication used to treat multiple sclerosis (MS). Marketed by Biogen Inc., this product is identified by NDC 59627-001 and is authorized under FDA application BLA103628.

Identification & Billing

NDC Package Code
59627-001-03
Package Description
4 TRAY in 1 CARTON / 1 VIAL, GLASS in 1 TRAY (59627-001-04) / 1 mL in 1 VIAL, GLASS
Product Code
59627-001
11-Digit Billing Format
59627000103
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Avonex
Dosage Form
-
Usage Information
This medication is used to treat multiple sclerosis (MS). Interferon is not a cure for MS, but it may help to slow disease worsening and decrease flare-ups of symptoms (such as balance problems, numbness, or weakness).

Regulatory & Marketing

Labeler Name
Biogen Inc.
FDA Application #
BLA103628
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
05-17-1996
End Marketing Date
04-10-2020
Listing Expiration
04-10-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59627-001-03 identifies a specific commercial package of 4 tray in 1 carton / 1 vial, glass in 1 tray (59627-001-04) / 1 ml in 1 vial, glass of Avonex, labeled by Biogen Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Biogen Inc. on May 17, 1996. The current certification is valid through April 10, 2020.

What are the primary indications for this medication?

This medication is used to treat multiple sclerosis (MS). Interferon is not a cure for MS, but it may help to slow disease worsening and decrease flare-ups of symptoms (such as balance problems, numbness, or weakness).

How is this Biogen Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59627000103. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59627-001-03
11-Digit CMS (5-4-2)
59627-0001-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.